Gemtuzumab: time to bring back on the market?

Clin Adv Hematol Oncol. 2012 May;10(5):326-7.
No abstract available

MeSH terms

  • Aminoglycosides / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Gemtuzumab
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Research
  • Safety-Based Drug Withdrawals
  • Treatment Outcome

Substances

  • Aminoglycosides
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Gemtuzumab